Skip to main content

Ingestible Sensors Market is Anticipated to Witness High Growth

Ingestible Sensors Market

The global ingestible sensors market is gaining significant traction over the past few years owing to an increase in technological advancements and innovations in healthcare sector. Ingestible sensors which are also called as smart pills, are electronic devices or capsules attached with sensors that can actively measure gut physiology. These sensors monitor various parameters such as body temperature, pH levels, pressure, images etc. once swallowed by the patient. The key advantages of ingestible sensors include non-invasiveness, real-time data monitoring, accuracy and improved patient compliance for treatment. With growing emphasis on preventive healthcare, these ingestible devices assist physicians for disease diagnoses at early stages without requiring surgical procedures.

The Global ingestible sensors Market is estimated to be valued at US$ 1,583.2 Mn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the ingestible sensors are CapsoVision, Inc., BodyCAP, etectRx, Koninklijke Philips N.V., Medtronic, Otsuka Holdings Co., Ltd., IntroMedic, JIHNSAN Science & Technology, Check-Cap, Proteus Digital Health Inc., and HQ, Inc. These leaders are focusing on new product launches and advancing their technologies capabilities. For instance, in 2021 Medtronic launched PillCam COLON 3 capsule endoscopy system to assist physicians in non-invasive colon cancer screening.

The key opportunities in the Ingestible Sensors Market Demand include increasing applications of ingestible sensors across various disease areas including gastrointestinal diseases, orthopedics, cardiology. For example, ingestible sensors are being used to monitor gastroparesis by measuring gastric emptying. Furthermore, several clinical trials are being conducted to evaluate efficacy of ingestible sensors in monitoring inflammatory bowel diseases and detecting early stage cancers.

Globally, North America dominates the ingestible sensors market due to rising adoption of advanced medical technologies and presence of prominent players in the US and Canada. However, Asia Pacific region is expected to witness fastest growth owing to growing medical tourism industry and improving access to healthcare in emerging countries like India and China. Several market players are expanding their manufacturing facilities in Asia to leverage lower costs and cater to rising local demand.

Market drivers and restrain

Market drivers- Increasing prevalence of gastrointestinal diseases globally is a major growth driver. According to NIH, over 70 million Americans are affected by digestive diseases annually. Moreover, rising geriatric population being more prone to chronic disorders will further drive the demand. Growing funding and investments by private and government bodies in developing advanced sensors based medical solutions is another key factor fueling the market growth.

Market restraints- High costs associated with these devices limit the adoption rates in developing regions. Moreover, lack of reimbursement policies also acts as a barrier. Other challenges include difficulty in remote data transfer from body and potential risks of device malfunctioning or damage. Stringent regulatory framework further delays the product approvals and commercialization.

Segment Analysis

The ingestible sensors market is dominated by capsule endoscopy sub segment. This is because capsule endoscopy offers non-invasive way of diagnosis of gastrointestinal disorders without any discomfort associated with conventional endoscopy procedures. Capsule endoscopy sensors are pre-programmed to take about 2-3 frames per second as it is naturally propelled through the gastrointestinal tract. Physicians prefer capsule endoscopy as it allows examination of small bowel which is not easily accessible through conventional endoscopy. Monitoring pills sub segment is anticipated to witness highest growth during forecast period due to benefits like continuous monitoring of vital signs without any patient discomfort.

Global Analysis

North America region holds largest share in ingestible sensors market due to supportive reimbursement policies, high awareness levels regarding advanced diagnostic methods, and presence of key industry players. Asia Pacific region is projected to witness highest growth rate during forecast period owing to increasing healthcare expenditure, large patient population for gastrointestinal disorders, and growing medical tourism. China dominates Asia Pacific region owing to improving healthcare infrastructure and increasing collaborations between domestic and international players for development of advanced ingestible technologies.

Get more insights on Ingestible Sensors Market

Comments

Popular posts from this blog

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at  US$ 2,334.2 Mn in 2024 , and is expected to exhibit a  CAGR of 5.2% , in terms of revenue, over the forecast period  2024-2031  to reach  US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...